Filings For: Aligos Therapeutics, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics

GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Aligos Therapeutics, Inc. (ALGS) 11/6/2026 8:11:42 AM Micro View Financials 10-Q SEC 3Q 2026 ending: 9/30/2026 Rev: $2,830,000 +281.9% Assets $47,189,000 EPS -$2.09
Aligos Therapeutics, Inc. (ALGS) 11/6/2026 8:01:18 AM   View Financials Earnings SEC 3Q 2026 Rev $2,830,000 +281.9% Assets $47,189,000 EPS -$2.09 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 8/6/2026 8:16:05 AM Micro View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Rev: $27,778,000 +2,778.5% Assets $66,327,000 EPS -$0.14
Aligos Therapeutics, Inc. (ALGS) 8/6/2026 8:02:36 AM   View Financials Earnings SEC 2Q 2026 Rev $27,778,000 +2,778.5% Assets $66,327,000 EPS -$0.14 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 5/7/2026 4:39:39 PM Micro View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Rev: $2,830,000 +810.0% Assets $64,558,000 EPS -$2.21
Aligos Therapeutics, Inc. (ALGS) 5/7/2026 4:19:54 PM   View Financials Earnings SEC 1Q 2026 Rev $2,830,000 +810.0% Assets $64,558,000 EPS -$2.21 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 4/29/2026 4:33:15 PM   View Proxy SEC Y 2025
Aligos Therapeutics, Inc. (ALGS) 3/5/2026 8:15:33 AM Micro View Financials 10-K SEC Y 2025 ending: 12/31/2025 Rev: $2,186,000 -39.5% Assets $88,533,000 EPS -$2.45
Aligos Therapeutics, Inc. (ALGS) 3/5/2026 8:03:09 AM   View Financials Earnings SEC Y 2025 Rev $169,000 -72.1% Assets $88,533,000 EPS -$2.01 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 11/6/2025 8:42:18 AM Micro View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Rev: $741,000 -40.7% Assets $109,764,000 EPS -$3.04
Aligos Therapeutics, Inc. (ALGS) 11/6/2025 8:32:07 AM   View Financials Earnings SEC 3Q 2025 Rev $741,000 -40.7% Assets $109,764,000 EPS -$3.04 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 8/6/2025 4:23:30 PM Micro View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Rev: $965,000 -9.0% Assets $134,706,000 EPS -$1.53
Aligos Therapeutics, Inc. (ALGS) 8/6/2025 4:08:14 PM   View Financials Earnings SEC 2Q 2025 Rev $965,000 -9.0% Assets $134,706,000 EPS -$1.53 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 5/6/2025 8:24:43 AM Small View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025 Rev: $311,000 -55.2% Assets $150,699,000 EPS -$2.11
Aligos Therapeutics, Inc. (ALGS) 5/6/2025 8:01:20 AM   View Financials Earnings SEC 1Q 2025 Rev $311,000 -55.2% Assets $150,699,000 EPS -$2.11 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 4/28/2025 4:07:06 PM   View Proxy SEC Y 2024
Aligos Therapeutics, Inc. (ALGS) 3/10/2025 8:12:28 AM Micro View Financials 10-K SEC Y 2024 ending: 12/31/2024 Rev: $3,611,000 -41.7% Assets $70,094,000 EPS -$20.94
Aligos Therapeutics, Inc. (ALGS) 3/10/2025 8:01:55 AM   View Financials Earnings SEC Y 2024 Rev $606,000 -9.8% Assets $70,094,000 EPS -$13.10 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 11/6/2024 4:43:48 PM Micro View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024 Rev: $1,250,000 +15.2% Assets $88,426,000 EPS -$3.07
Aligos Therapeutics, Inc. (ALGS) 11/6/2024 4:06:15 PM   View Financials Earnings SEC 3Q 2024 Rev $1,250,000 +15.2% Assets $88,426,000 EPS -$3.07 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 8/6/2024 4:28:30 PM Micro View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024 Rev: $1,061,000 -75.3% Assets $108,811,000 EPS $0.03
Aligos Therapeutics, Inc. (ALGS) 8/6/2024 4:09:43 PM   View Financials Earnings SEC 2Q 2024 Rev $1,061,000 -75.3% Assets $108,811,000 EPS $0.03 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 5/7/2024 4:24:55 PM Micro View Financials 10-Q SEC 1Q 2024 ending: 3/31/2024 Rev: $694,000 +395.7% Assets $127,902,000 EPS -$5.58
Aligos Therapeutics, Inc. (ALGS) 5/7/2024 4:12:19 PM   View Financials Earnings SEC 1Q 2024 Rev $694,000 +395.7% Assets $127,902,000 EPS -$5.58 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 4/29/2024 4:01:46 PM   View Proxy SEC Y 2023
Aligos Therapeutics, Inc. (ALGS) 3/12/2024 4:29:13 PM Small View Financials 10-K SEC Y 2023 ending: 12/31/2023 Rev: $6,191,000 Assets $151,527,000 EPS -$34.20
Aligos Therapeutics, Inc. (ALGS) 3/12/2024 4:07:48 PM   View Financials Earnings SEC Y 2023 Rev $672,000 Assets $151,527,000 EPS $0.39 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 11/2/2023 4:38:33 PM Micro View Financials 10-Q SEC 3Q 2023 ending: 9/30/2023 Rev: $1,085,000 Assets $85,852,000 EPS -$10.37
Aligos Therapeutics, Inc. (ALGS) 11/2/2023 4:08:11 PM   View Financials Earnings SEC 3Q 2023 Rev $1,085,000 Assets $85,852,000 EPS -$10.37 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 8/3/2023 4:40:10 PM Micro View Financials 10-Q SEC 2Q 2023 ending: 6/30/2023 Rev: $4,294,000 Assets $106,130,000 EPS -$0.43
Aligos Therapeutics, Inc. (ALGS) 8/3/2023 4:09:39 PM   View Financials Earnings SEC 2Q 2023 Rev $4,294,000 Assets $106,130,000 EPS -$0.43 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 6/2/2023 4:08:12 PM   View Proxy SEC Y 2022
Aligos Therapeutics, Inc. (ALGS) 5/4/2023 4:33:10 PM Micro View Financials 10-Q SEC 1Q 2023 ending: 3/31/2023 Rev: $140,000 -94.6% Assets $121,738,000 EPS -$0.53
Aligos Therapeutics, Inc. (ALGS) 5/4/2023 4:12:35 PM   View Financials Earnings SEC 1Q 2023 Rev $140,000 -94.6% Assets $121,738,000 EPS -$0.53 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 4/28/2023 5:00:34 PM   View Proxy SEC Y 2022
Aligos Therapeutics, Inc. (ALGS) 3/9/2023 4:30:33 PM Small View Financials 10-K SEC Y 2022 ending: 12/31/2022 Assets $146,693,000 EPS -$2.25
Aligos Therapeutics, Inc. (ALGS) 3/9/2023 4:06:20 PM   View Financials Earnings SEC Y 2022 Rev $0 Assets $146,693,000 EPS -$0.51 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 11/2/2022 4:27:33 PM Small View Financials 10-Q SEC 3Q 2022 ending: 9/30/2022 Assets $164,069,000 EPS -$0.44
Aligos Therapeutics, Inc. (ALGS) 11/2/2022 4:10:09 PM   View Financials Earnings SEC 3Q 2022 Rev $0 Assets $164,069,000 EPS -$0.44 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 8/4/2022 4:59:16 PM Small View Financials 10-Q SEC 2Q 2022 ending: 6/30/2022 Assets $182,523,000 EPS -$0.47
Aligos Therapeutics, Inc. (ALGS) 8/4/2022 4:13:33 PM   View Financials Earnings SEC 2Q 2022 Rev $0 Assets $182,523,000 EPS -$0.47 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 5/4/2022 4:47:35 PM Small View Financials 10-Q SEC 1Q 2022 ending: 3/31/2022 Rev: $2,571,000 +182.5% Assets $210,470,000 EPS -$0.84
Aligos Therapeutics, Inc. (ALGS) 5/4/2022 4:08:46 PM   View Financials Earnings SEC 1Q 2022 Rev $2,571,000 +182.5% Assets $210,470,000 EPS -$0.84 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 4/29/2022 6:26:53 AM   View Proxy SEC Y 2021
Aligos Therapeutics, Inc. (ALGS) 3/10/2022 4:34:34 PM Small View Financials 10-K SEC Y 2021 ending: 12/31/2021 Rev: $4,359,000 Assets $235,369,000 EPS -$3.22
Aligos Therapeutics, Inc. (ALGS) 3/10/2022 4:06:55 PM   View Financials Earnings SEC Y 2021 Rev $367,000 Assets $235,369,000 EPS -$0.91 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 11/4/2021 4:33:32 PM Small View Financials 10-Q SEC 3Q 2021 ending: 9/30/2021 Rev: $1,537,000 Assets $263,068,000 EPS -$0.78
Aligos Therapeutics, Inc. (ALGS) 11/4/2021 4:11:20 PM   View Financials Earnings SEC 3Q 2021 Rev $1,537,000 Assets $263,068,000 EPS -$0.78 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 8/5/2021 4:53:43 PM Small View Financials 10-Q SEC 2Q 2021 ending: 6/30/2021 Rev: $1,545,000 Assets $211,876,000 EPS -$0.79
Aligos Therapeutics, Inc. (ALGS) 8/5/2021 4:11:46 PM   View Financials Earnings SEC 2Q 2021 Rev $1,545,000 Assets $211,876,000 EPS -$0.79 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 5/10/2021 4:33:50 PM Small View Financials 10-Q SEC 1Q 2021 ending: 3/31/2021 Rev: $910,000 Assets $234,540,000 EPS -$0.74
Aligos Therapeutics, Inc. (ALGS) 5/10/2021 4:08:27 PM   View Financials Earnings SEC 1Q 2021 Rev $910,000 Assets $234,540,000 EPS -$0.74 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 4/27/2021 4:19:27 PM   View Proxy SEC Y 2020
Aligos Therapeutics, Inc. (ALGS) 3/23/2021 4:35:14 PM Small View Financials 10-K SEC Y 2020 ending: 12/31/2020 Assets $265,302,000 EPS -$10.87
Aligos Therapeutics, Inc. (ALGS) 3/23/2021 4:06:26 PM   View Financials Earnings SEC Y 2020 Assets $265,302,000 EPS $15.33 Export Earnings Model
Aligos Therapeutics, Inc. (ALGS) 11/25/2020 5:36:16 PM Micro View Financials 10-Q SEC 3Q 2020 ending: 9/30/2020 Assets $92,183,000 EPS -$11.00